The purpose of this study was to develop a psychometrically sound shortened version of an existing measure of lung cancer stigma for use by researchers and clinicians. Lung cancer stigma is an influential variable in the timing of help-seeking behavior in individuals with symptoms suggestive of lung cancer (Cataldo, Slaughter, 
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in the context of two factors: a person's perception of societal attitudes toward both smoking and lung cancer and a personal knowledge of having lung cancer" (Cataldo et al., 2011, p. E47) . The CLCSS was modified for use in a sample of lung cancer patients.
Content validity of the original scale was ensured by the inclusion of experts on stigma from psychology, sociology, oncology, and nursing. If an item was rejected by more than one of the seven reviewers, it was discarded or rewritten resulting in a reduction of the original 45-item scale to 37 items. Nine additional items were developed, reviewed, and accepted by the content experts resulting in a 46-item scale initially. The CLCSS is based upon a 4-point Likert scale anchored by 1 (strongly disagree) and 4 (strongly agree).
Psychometric testing of the original scale was conducted with 186 lung cancer patients (Cataldo et al., 2011) . Construct validity was supported and involved exploratory factor analysis which revealed four underlying subscales: (a) stigma and shame, (b) social isolation, (c) discrimination, and (d) smoking. The four-factor solution explained 57% of the variance. According to Stevens (2009) , greater than 50% cumulative explained variance is considered 'excellent' in factor analysis. Using an eigenvalue greater > 1 criterion for the subscales and a loading cutoff of .35, 43 of the 46 items were retained. Criterion-related validity was supported by examining the relationship of the 43-item instrument with the pre-identified related constructs (Cataldo et al., 2011) : self-esteem (measured using the Rosenberg Self-Esteem Scale; Wiley, 1989) , depression (measured using the Center for Epidemiologic Studies-Depression Scale; Hoover et al., 1993) , social support and social conflict (both measured using the Social Support indices; O'Brien, Wortman, Kessler, & Joseph, 1993) , and quality of life ! 5! (measured using the Quality of Life Inventory; Ferrell, Wisdom, & Wenzl, 1989) . Internal consistency reliability was assessed with Cronbach's alpha and was noted to be .98. The Cronbach's alphas for the four subscales were: .97 (stigma and shame), .98 (social isolation), .95 (discrimination), and .75 (smoking).
The original CLCSS was then shortened to a 31-item lung cancer stigma scale to decrease patient burden after it was determined the scale could be shortened while maintaining an adequate internal consistency reliability (Cataldo et al., 2011) . The 31-item, 4-point Likert scale has a range from 31 (reflecting low levels of lung cancer stigma) to 124 (reflecting high levels of lung cancer stigma). In the factor analysis for the original scale by Cataldo et al. (2011) The CLCSS is a relatively new instrument and, to date, has been used in two published studies. Cataldo, Jahan, and Pongquan (2012) used the CLCSS to examine lung cancer stigma in lung cancer patients with depression; Lee and Kim (2011) used the CLCSS to examine the relationships of lung cancer stigma, distress, and quality of life in lung cancer patients. Both studies supported the reliability and validity of the instrument.
Procedure
The university institutional review board and review committees at both recruitment sites approved the study. Data were collected in-person using a selfadministered survey in the clinic prior to an oncology visit. Data were analyzed using the Statistical Program for Social Sciences software version 20.0 (SPSS, 2012).
Dimensionality of the 31 items of the CLCSS was evaluated using principal components analysis. To assess the suitability of the data for factor analysis, Bartlett's test for sphericity and the Kaiser-Meyer-Olkin (KMO) statistic were used. Eigenvalues greater than 1 were examined first but those located above the elbow on the scree plot were used to make the final determination of the number of factors to retain for rotation.
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Reliability statistics including Cronbach's alpha, corrected item-total correlations, and alphas-if-item-deleted were used for scale and subscale refinement. Principal components analysis with varimax rotation was performed.
Results

Sample Characteristics
Characteristics of the sample are summarized in Table 1 . The majority of participants were female, married, and age 60 years or older. More than three-fourths had advanced stage lung cancer.
Psychometric Testing of the Original CLCSS
Dimensionality.
Cronbach's alpha for the 31 items was .95, indicating excellent internal consistency reliability but potential item redundancy. Three principal components analyses were run. The significant Bartlett's test of sphericity (p < .001) and the high KMO index (.87) indicated that the data were appropriate for this analysis. On the basis of the scree plot, one primary component emerged explaining 50% of the variance. Four other components had eigenvalues greater than 1. These components explained an additional 9%, 7%, 5%, and 4% of the variance. In examining the component matrix, 23 items loaded strongly on the first component, three items loaded strongly on the second component, and one item loaded strongly on the fourth component. The third component did not have any strong loadings; four items double loaded. After further examination of the scree plot, three factors were retained for rotation. Nine items had double loadings and one item had low loadings on all three components (See Table 2 ).
Items were eliminated if they had double loadings (defined as a minimum of .32; Fidell, 2001 ). These 10 items were excluded and a final principal components analysis with varimax rotation of three factors was run with the remaining 21 items (see Table 3 ). All items loaded strongly on either the first, second or third component. No double loadings were noted. Items loading on each factor were examined and the three factors were named. Factor 1 -shame and blame-had eight loadings that ranged from .60 to .83. Factor 2 -social isolation-had nine loadings that ranged from .47 to .88. Factor 3 -discrimination -had four primary loadings that ranged from .74 to .94. The three factors explained 68% of the item variance.
Internal consistency reliability.
Table 4 provides a summary of the reliability coefficients of the original CLCSS and subscales and the shortened version of the CLCSS and subscales. All three subscales of the shortened version had strong internal consistency reliability. The item with the lowest corrected item-total correlation (.37) was My lung cancer diagnosis was delayed because my healthcare provider did not take my "smoker's cough" seriously.
For the revised CLCSS, the corrected item-total correlations for Factor 1 (shame and blame subscale) ranged from .58 to .86, Factor 2 (social isolation subscale) ranged from .37 to .85, and Factor 3 (discrimination subscale) ranged from .70 to .89. There were moderate intercorrelations among the subscales: .69 between shame and blame and social isolation; .47 between shame and blame and discrimination; and .44 between social isolation and discrimination. All intercorrelations were statistically significant (p < .001).
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Discussion
In this study, we examined the psychometric properties of the original CLCSS (Cataldo et al., 2011) and developed a short version for use by researchers and clinicians working with lung cancer patients. In a sample of lung cancer patients, the original CLCSS had excellent internal consistency reliability but potential item redundancy. The original scale contains 31 items and evidence to support reliability and validity (Cataldo et al., 2011; Cataldo et al., 2012; Lee & Kim, 2011) . By examining the dimensionality of the original CLCSS, we were able to shorten the scale to 21 items and improve the practicality of the instrument's use in research and clinical practice. The shorter version will also reduce lung cancer patient burden with questionnaire completion.
In our sample, internal consistency reliability of the three subscales of the short version were strong and ranged from .89 to .92; all scale items strongly loaded onto only one factor. Cronbach's alpha for the total 21-item scale (.93) demonstrated strong evidence of internal consistency reliability of the short measure in this sample of lung cancer patients.
From a clinical standpoint, the subscales of the short version of the CLCSS offer an opportunity to tailor lung cancer stigma assessment and interventions. For example, if an individual lung cancer patient is a never smoker and scores high on the social isolation subscale but low on the smoking and shame and blame subscales, interventions can be tailored to focus on the social isolation aspect of a lung cancer diagnosis. Future research should be focused on validation of the short version of the CLCSS and its subscales.
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Limitations
The average age of a lung cancer patient is 71 years (ACS, 2013) . The average age of the participants in this study was 62 years. Younger individuals may perceive stigma differently than their older counterpart. In addition, sample size may be a weakness. Although the sample size was sufficient for factor analysis, future studies testing the psychometric properties of the shortened version of the CLCSS should use larger samples.
Conclusion
Lung cancer stigma is an important phenomenon experienced by many lung cancer patients. Perceived stigma in individuals with lung cancer can serve as a barrier to healthcare help-seeking behavior, treatment adherence, and social support. The 21-item version of the CLCSS had strong evidence of reliability. In comparison to the original CLCSS, this short version may decrease patient burden and be more applicable to clinicians; however, future research is needed to further examine its psychometric properties.
! Table 1 Characteristics 
